These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20458765)

  • 1. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
    Wang LH; Cheng H; Hu FL; Li J
    World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
    Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M
    Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
    Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
    Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
    Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
    Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
    Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
    BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
    Bogaerts P; Berhin C; Nizet H; Glupczynski Y
    Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point Mutations at
    López-Gasca M; Peña J; García-Amado MA; Michelangeli F; Contreras M
    Am J Trop Med Hyg; 2018 Apr; 98(4):1051-1055. PubMed ID: 29405113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
    Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
    Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France.
    Garcia M; Raymond J; Garnier M; Cremniter J; Burucoa C
    Antimicrob Agents Chemother; 2012 Jan; 56(1):550-1. PubMed ID: 22064536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
    Kim JM; Kim JS; Kim N; Jung HC; Song IS
    J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using next-generation sequencing to analyze Helicobacter pylori clones with different levofloxacin resistances from a patient with eradication failure.
    Ye L; Meng F; Mao X; Zhang Y; Wang J; Liu Y; Zhu W; Gu B; Huang Q
    Medicine (Baltimore); 2020 Aug; 99(32):e20761. PubMed ID: 32769862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.
    Luzarraga V; Cremniter J; Plouzeau C; Michaud A; Broutin L; Burucoa C; Pichon M
    J Antimicrob Chemother; 2024 Oct; 79(10):2633-2639. PubMed ID: 39126340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children.
    Fujimura S; Kato S; Iinuma K; Watanabe A
    J Med Microbiol; 2004 Oct; 53(Pt 10):1019-1022. PubMed ID: 15358825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.
    Sun C; Hao J; Dou M; Gong Y
    J Antibiot (Tokyo); 2015 May; 68(5):313-7. PubMed ID: 25351948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point Mutations at gyrA and gyrB Genes of Levofloxacin Resistant Helicobacter pylori Strains and Dual Resistance with Clarithromycin.
    Ziver-Sarp T; Yuksel-Mayda P; Saribas S; Demiryas S; Gareayaghi N; Ergin S; Tasci I; Ozbey D; Bal K; Erzin Y; Akkus S; Bahar-Tokman H; Demirci M; Tufan-Kocak B; Kocazeybek B
    Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
    Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
    Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.